Is the influence of variation in the ACE gene on the prospective risk of Type 2 diabetes in middle-aged men modified by obesity?

Clinical Science

Volumn 113, Issue 11-12, 2007, Pages 467-472

  Muthumala, Amal ^a   Gable, David R ^a   Palmen, Jutta ^a   Cooper, Jackie A ^a   Stephens, Jeffrey W ^b   Miller, George J ^c   Humphries, Steve E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotenin II; Angiotensin converting enzyme gene (ACE gene); Body mass index (BMI); Gene environment interaction; Inflammatory state; Obesity; Type 2 diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FOLLOW UP; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE INTERACTION; GENETIC VARIABILITY; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; PEPTIDYL-DIPEPTIDASE A; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 36849079823     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070158     Document Type: Article

References (32)

1. Karlsson, C., Lindell, K., Ottosson, M., Sjostrom, L., Carlsson, B. and Carlsson, L. M. S. (1998) Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J. Clin. Endocrinol. Metab. 83, 3925-3929
2. Ogihara, T., Asano, T., Ando, K. et al. (2002) Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40, 872-879
3. Scheen, A. J. (2004) Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 1. A meta-analysis of randomised clinical trials. Diabetes Metab. 30, 487-496
4. Rigat, B., Hubert, C., Alhenc-Gelas, F, Cambien, F, Corvol, P. and Soubrier, F. (1990) An insertion deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346
5. Danser, A. H. J., Schalekamp, M. A. D. H., Bax, W. A. et al. (1995) Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92, 1387-1388
6. Grammer, T. B., Renner, W., von Karger, S., Boehm, B. O., Winkelmann, B. R. and Maerz, W. (2006) The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol. Genet. Metab. 88, 378-383
7. Schmidt, S. and Ritz, E. (1997) Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol. Dial. Transplant. 12, 37-41
8. Stephens, J. W., Dhamrait, S. S., Cooper, J. A. et al. (2005) The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol. Genet. Metab. 84, 83-89
9. Kennon, B., Petrie, J. R., Small, M. and Connell, J. M. C. (1999) Angiotensin-converting enzyme gene and diabetes mellitus. Diabetic Med. 16, 448-458
10. Salonen, J., Kesaniemi, Y. A. and Ukkola, O. (2006) Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients. Eur. J. Intern. Med. 17, 115-119
11. Panahloo, A., Andres, C., Mohamed-Ali, V. et al. (1995) The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Circulation 92, 3390-3393
12. Sayed-Tabatabaei, F. A., Schut, A. F. C., Arias Vasquez, A. et al. (2005) Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study. J. Med. Genet. 42, 26-30
13. Schut, A. F. C., Bleumink, G. S., Stricker, B. H. C. et al. (2004) Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur. Heart J. 25, 2143-2148
14. Osawa, N., Koya, D., Araki, S. et al. (2007) Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J. Hum. Genet. 52, 143-151
15. Ng, D. P. K., Placha, G., Choo, S., Chia, K. s., Warram, J. H. and Krolewski, A. S. (2006) A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55, 2660-2663
16. Florez, J. C., Jablonski, K. A., Sun, M. W. et al. (2007) Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J. Clin. Endocrinol. Metab. 92, 1502-1509
17. Florez, J. G., Jablonski, K. A., Bayley, N. et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241-250
18. Gable, D. R., Stephens, J. W., Cooper, J. A., Miller, G. J. and Humphries, S. E. (2006) Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men. Diabetes 55, 1504-1511
19. Miller, G. J., Bauer, K. A., Barzegar, S. et al. (1995) The effects of quality and timing of venipuncture on markers of blood-coagulation in healthy middle-aged men. Thromb. Haemostasis 73, 82-86
20. O'Dell, S. D., Humphries, S. E. and Day, I. N. M. (1995) Rapid methods for population-scale analysis for gene polymorphisms: the ace gene as an example. Br. Heart J. 73, 368-371
21. Tanaka, G., Kamide, K., Takiuchi, S. et al. (2003) An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens. Res. 26, 301-306
22. Humphries, S. E., Gable, D. R., Cooper, J. A. et al. (2006) Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J. Mol. Med. V84, 1005-1014
23. Dhamrait, S. S., Stephens, J. W., Cooper, J. A. et al. (2004) Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur. Heart J. 25, 468-475
24. Hattori, Y., Akimoto, K., Gross, S. S., Hattori, S. and Kasai, K. (2005) Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 48, 1066-1074
25. Leung, P. S. and Carlsson, P. O. (2005) Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas 30, 293-298
26. Engeli, S., Schling, P., Gorzelniak, K. et al. (2003) The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int. J. Biochem. Cell Biol. 35, 807-825
27. The Dream Trial Investigators (2006) Effect of ramipril on the incidence of diabetes. N. Engl. J. Med. 355, 1551-1562
28. 1 receptor and intracellular kinase gene expression in hypertensive rats. Clin. Exp. Pharmacol. Physiol. 33, 690-695
29. Wang, X. L., Zhang, L., Youker, K. et al. (2006) Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55, 2301-2310
30. Bakker, S. J. L., IJzerman, R. G., Teerlink, T., Westerhoff, H. V., Gans, R. O. B. and Heine, R. J. (2000) Cytosolic triacylglycerols and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and β-cell failure? Atherosclerosis 148, 17-21
31. Xu, J. W., Morita, I., Ikeda, K., Miki, T. and Yamori, Y. (2007) C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase. Mol. Endocrinol. 21, 564-573
32. Humphries, S. E., Hawe, E., Dhamrait, S., Miller, G. J. and Talmud, P. J. (2003) In search of genetic precision. Lancet 361, 1908-1909